公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Targeting VCP potentiates immune checkpoint therapy for colorectal cancer	7
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	C-Jun/C7ORF41/NF-κB axis mediates hepatic inflammation and lipid accumulation in NAFLD	4	Biochemical Journal
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	N-Linked Glycosylation and Expression of Duck Plague Virus pUL10 Promoted by pUL49. 5	4	Microbiology Spectrum
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Poly (ADP-ribosylation) of HMGB1 facilitates its acetylation and promotes HMGB1 translocation-associated chemotherapy-induced autophagy in leukaemia …	2	Cell death discovery
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	A novel lncRNA linc-AhRA negatively regulates innate antiviral response in murine microglia upon neurotropic herpesvirus infection	13	Journal of Experimental Botany
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	hnRNPA2B1 represses the disassembly of arsenite-induced stress granules and is essential for male fertility	9	Cell Reports
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation	4	Frontiers in Oncology
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells	7	J Exp Clin Cancer Res
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	An arms race between 5'ppp-RNA virus and its alternative recognition receptor MDA5 in RIG-I-lost teleost fish		Biochim Biophys Acta
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin‑mediated autophagy	2	Mol Med Rep

首页上一页 393 394 395 396 397 398 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部